{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:28:42Z","timestamp":1649186922190},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.leukres.2008.02.001","type":"journal-article","created":{"date-parts":[[2008,3,24]],"date-time":"2008-03-24T13:45:04Z","timestamp":1206366304000},"page":"1468-1471","source":"Crossref","is-referenced-by-count":0,"title":["Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate"],"prefix":"10.1016","volume":"32","author":[{"given":"Arturo","family":"Vega-Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partow","family":"Kebriaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Ravandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.02.001_bib1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/cncr.22881","article-title":"Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia","volume":"110","author":"Piccaluga","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.02.001_bib2","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.02.001_bib3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2005-11-4386","article-title":"Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)","volume":"108","author":"Wassman","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.02.001_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","article-title":"High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group","volume":"24","author":"Yanada","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2008.02.001_bib5","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","article-title":"Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia","volume":"108","author":"Kovitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.02.001_bib6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","article-title":"Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia","volume":"18","author":"Terre","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.02.001_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/cncr.22936","article-title":"The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells","volume":"110","author":"Deiniger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.02.001_bib8","first-page":"556","article-title":"Clonal cytogenetics abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate","volume":"90","author":"Espinet","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2008.02.001_bib9","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.22699","article-title":"Characterization of Ph-negative abnormal clones emerging during imatinib therapy","volume":"109","author":"Abruzzese","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.02.001_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.leu.2402848","article-title":"Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous during major cytogenetic responses induced by imatinib mesylate","volume":"17","author":"O\u2019Dwyer","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.02.001_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.leu.2402791","article-title":"Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib","volume":"17","author":"Meeus","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.02.001_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ajh.20859","article-title":"Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome","volume":"82","author":"Navarro","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2008.02.001_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.leu.2402842","article-title":"Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterized by the emergence of complex Philadelphia negative clones","volume":"17","author":"Chee","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.02.001_bib14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2403037","article-title":"Myelodysplastic features developing in Philadelphia-negative cells during imatinib mesylate therapy for CML: report of a new case","volume":"17","author":"Mozziconacci","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.02.001_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00292-005-0806-x","article-title":"Hematological side effects of tyrosine kinase inhibition using imatinib","volume":"27","author":"Schmitt-Graeff","year":"2006","journal-title":"Pathologe"},{"key":"10.1016\/j.leukres.2008.02.001_bib16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal abnormalities in Ph-cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.02.001_bib17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3324\/haematol.11034","article-title":"Therapy related leukemia and myelodysplasia: susceptibility and incidence","volume":"92","author":"Leone","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2008.02.001_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.leu.2400928","article-title":"Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemias","volume":"12","author":"Relling","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.02.001_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.leu.2401391","article-title":"Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement","volume":"13","author":"Bigoni","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.02.001_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1309\/XY44-L8TE-PWU5-62MP","article-title":"11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetics analyses","volume":"114","author":"Ibrahim","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2008.02.001_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yexmp.2006.04.002","article-title":"Acute lymphoblastic leukemia with 4;11 translocation analyzed by a multi-modal strategy of conventional cytogenetics, FISH, morphology, flow cytometry and molecular genetics, and review of the literature","volume":"81","author":"Hayne","year":"2006","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.leukres.2008.02.001_bib22","first-page":"4674","article-title":"Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate","volume":"9","author":"Pfeifer","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2008.02.001_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/10428190310001625728","article-title":"Central nervous system failure in patients with chronic myeloid leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571)","volume":"45","author":"Leis","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2008.02.001_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/10428190310001593184","article-title":"Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy","volume":"45","author":"Bujassoum","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2008.02.001_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.2002.03881.x","article-title":"Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid","volume":"119","author":"Takayama","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.02.001_bib26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.leukres.2007.03.018","article-title":"What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph(+) ALL?","volume":"31","author":"Mele","year":"2007","journal-title":"Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T20:55:45Z","timestamp":1546203345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0145212608000738"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.02.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}